ÂÜÀòÂÒÂ×

Dr. Hervieu is a trained cell biologist with expertise in tumor biology, signal transduction, and translational research with particular focus on target identification/validation and PD biomarker development. Alexia received her Ph.D. in Tumor Biology from Queen Mary University of London at Barts Cancer Institute, where her work unravelled molecular downstream signalling of the oncogene cMet. Following this, Alexia obtained a post-doctorate fellowship at The Institute of Cancer Research, within the Cancer Research UK Cancer Therapeutic Unit, working on target identification to be considered for potential drug discovery project. Those investigations lead to the identification of druggable targets in a specific tumor type, together with the molecular mechanisms driving tumoral activity.